leading pharmaceutical

Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry [A book review from: Technovation]
$4.95
This digital document is a journal article from Technovation, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:

2004 Executive's Guide to the World's Leading Pharmaceutical and Biotechnology Companies
$395.00
Really enjoyed reading the guide, an excellent review of the current state of the industry with in-depth analysis on all the top 50 pharma and biotech companies. Really well written and easy to read with some good rankings tables. Essential reading for all senior execs and great value for money.

How to Realize the Potential of Business Customer Communities: A case study fo a leading-edge pharmaceutical company
$121.00
In the past the core of business-to-business marketing was to create and transfer information about products and services to customers. Today, as a result of the Internet revolution, this information is becoming commonly available. Due to information transparency, traditional linear marketing and sales approaches - focused on transferring information to customers - are reaching their limits. In his thesis, Dr. Pablo Erat argues that organizations in the business-to-business sector can profit from a customer marketing and service approach that is based on the enabling of customer communities. Based on an in-depth case study, he identifies four major challenge areas and demonstrates how these can be addressed in order to create well functioning communities and improve the sales performance.

Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry
$74.95
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia. ?